SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Nycomed seeks damages from Sun Pharmaceuticals, Teva

30 Sep 2010 Evaluate

Nycomed, would seek damages from Sun Pharmaceuticals and Israel-based Teva in the US for patent infringement of Pantoprazole. The company has got a favorable judgement in a lawsuit against Sun and Teva in the US over the patent infringement of Pantoprazole. Now its lawsuit for seeking damages is going on in a US court. The judgement for the same is expected after 12-months.

crackcrack

Sun Pharma Inds. Share Price

1668.00 -7.20 (-0.43%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×